Avadel Pharmaceuticals earnings were -$26.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest AVDL earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$4.9M, down 2.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVDL reported annual earnings of -$48.8M, with -69.5% growth. The next AVDL earnings date is Aug 6, 2025.
Avadel Pharmaceuticals Earnings Reports & History FAQ
What were Avadel Pharmaceuticals's earnings last quarter?
On AVDL's earnings call on Invalid Date, Avadel Pharmaceuticals (NASDAQ: AVDL) reported Q1 2025 earnings per share (EPS) of -$0.05, up 83.33% year over year. Total AVDL earnings for the quarter were -$4.92 million. In the same quarter last year, Avadel Pharmaceuticals's earnings per share (EPS) was -$0.30.
The next AVDL earnings call is Invalid Date. Add AVDL to your watchlist to be reminded of Avadel Pharmaceuticals's next earnings date.
Is Avadel Pharmaceuticals profitable or losing money?
As of the last Avadel Pharmaceuticals earnings report, Avadel Pharmaceuticals is currently losing money. Avadel Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$26.41 million, a 83.16% decrease year over year.
What was AVDL's earnings growth in the past year?
As of Avadel Pharmaceuticals's earnings date in Invalid Date, Avadel Pharmaceuticals's earnings has grown year over year. AVDL earnings in the past year totalled -$26.41 million.
What are Avadel Pharmaceuticals's earnings expectations?
The current EPS estimate for Avadel Pharmaceuticals's earnings report in Invalid Date is $0.04.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.